Cargando…

Lessons from two prevalent amyloidoses—what amylin and Aβ have in common

The amyloidogenic peptide Aβ plays a key role in Alzheimer's disease (AD) forming insoluble aggregates in the brain. The peptide shares its amyloidogenic properties with amylin that forms aggregates in the pancreas of patients with Type 2 Diabetes mellitus (T2DM). While epidemiological studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Götz, Jürgen, Lim, Yun-An, Eckert, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3737661/ https://www.ncbi.nlm.nih.gov/pubmed/23964237 http://dx.doi.org/10.3389/fnagi.2013.00038

Ejemplares similares

Amylin Receptor: A Common Pathophysiological Target in Alzheimer’s Disease and Diabetes Mellitus
por: Fu, Wen, et al.
Publicado: (2013)

Systemic amyloidoses and proteomics: The state of the art
por: Lavatelli, Francesca, et al.
Publicado: (2016)

Oxidative Stress, Chronic Inflammation, and Amyloidoses
por: Orzechowski, Arkadiusz, et al.
Publicado: (2019)

Advances in diagnostics and therapy of systemic amyloidoses
por: Jamroziak, Krzysztof, et al.
Publicado: (2020)

Amyloïdose induite par l’insuline
por: Kano, Yasuhiro
Publicado: (2023)

Stress Response Is the Main Trigger of Sporadic Amyloidoses
por: Galkin, Alexey P., et al.
Publicado: (2021)

Structure of Tau filaments in Prion protein amyloidoses
por: Hallinan, Grace I., et al.
Publicado: (2021)

Kardiale Amyloidose: Aktuelle und zukünftige Therapieoptionen
por: Knoll, Katharina, et al.
Publicado: (2023)

DES-Amyloidoses “Amyloidoses through the looking-glass”: A knowledgebase developed for exploring and linking information related to human amyloid-related diseases
por: Bajic, Vladan P., et al.
Publicado: (2022)

Role and Cytotoxicity of Amylin and Protection of Pancreatic Islet β-Cells from Amylin Cytotoxicity
por: Kiriyama, Yoshimitsu, et al.
Publicado: (2018)

A scFv antibody targeting common oligomeric epitope has potential for treating several amyloidoses
por: Zha, Jun, et al.
Publicado: (2016)

Amyloïdose féline à expression hépatique chez 2 chats()
por: Derré, G., et al.
Publicado: (2014)

Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?
por: Qiu, Wei Qiao, et al.
Publicado: (2014)

Amylin in the Periphery
por: Wookey, Peter J., et al.
Publicado: (2003)

Treating Protein Misfolding Diseases: Therapeutic Successes Against Systemic Amyloidoses
por: Nevone, Alice, et al.
Publicado: (2020)

The Importance of a Gatekeeper Residue on the Aggregation of Transthyretin: IMPLICATIONS FOR TRANSTHYRETIN-RELATED AMYLOIDOSES
por: Sant'Anna, Ricardo, et al.
Publicado: (2014)

Enzymatic remodeling of heparan sulfate: a therapeutic strategy for systemic and localized amyloidoses?
por: Nishitsuji, Kazuchika, et al.
Publicado: (2016)

Amyloidoses in Onco-Nephrology Practice: A Multidisciplinary Case-Based Conference Report
por: Kitchlu, Abhijat, et al.
Publicado: (2023)

The Roles of Amylin in the Periphery
por: Wookey, P. J., et al.
Publicado: (2001)

The association of circulating amylin with β‐amyloid in familial Alzheimer's disease
por: Ly, Han, et al.
Publicado: (2021)

Impact of Deuteration on the Assembly Kinetics of Transthyretin Monitored by Native Mass Spectrometry and Implications for Amyloidoses
por: Yee, Ai Woon, et al.
Publicado: (2016)

What do temporal lobe epilepsy and progressive mild cognitive impairment have in common?
por: Höller, Yvonne, et al.
Publicado: (2014)

Novel insights into amylin aggregation
por: Pillay, Karen, et al.
Publicado: (2014)

Monoconjugation of Human Amylin with Methylpolyethyleneglycol
por: Sisnande, Tháyna, et al.
Publicado: (2015)

Calcitonin/Amylin Receptors and Ramps
por: Sexton, Patrick M.
Publicado: (2001)

Amylin as a Neuroendocrine Hormone
por: Young, Andrew A.
Publicado: (2001)

High-Fat Diet Increases Amylin Accumulation in the Hippocampus and Accelerates Brain Aging in hIAPP Transgenic Mice
por: Xi, Xiao-Xia, et al.
Publicado: (2019)

Feasibility of Amylin Imaging in Pancreatic Islets with β-Amyloid Imaging Probes
por: Yoshimura, Masashi, et al.
Publicado: (2014)

Patient experience with hereditary and senile systemic amyloidoses: a survey from the Amyloidosis Research Consortium
por: Lousada, Isabelle, et al.
Publicado: (2015)

Amylin – Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity
por: Boyle, Christina Neuner, et al.
Publicado: (2017)

What Renders TAU Toxic
por: Götz, Jürgen, et al.
Publicado: (2013)

Mediators of Amylin Action in Metabolic Control
por: Boyle, Christina N., et al.
Publicado: (2022)

Amylin as a Future Obesity Treatment
por: Dehestani, Babak, et al.
Publicado: (2021)

Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicity
por: Eckert, Anne, et al.
Publicado: (2011)

Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation
por: Fu, Wen, et al.
Publicado: (2017)

A cationic polymethacrylate-copolymer acts as an agonist for β-amyloid and an antagonist for amylin fibrillation
por: Sahoo, Bikash R., et al.
Publicado: (2019)

Rapid, scalable assay of amylin-β amyloid co-aggregation in brain tissue and blood
por: Kotiya, Deepak, et al.
Publicado: (2023)

Amylin at the interface between metabolic and neurodegenerative disorders
por: Lutz, Thomas A., et al.
Publicado: (2015)

Charge-Based Inhibitors of Amylin Fibrillization and Toxicity
por: Patil, Sharadrao M., et al.
Publicado: (2015)

Amylin in the Periphery II: An Updated Mini-Review
por: Wookey, Peter J., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_u7574fl7lkapvjvh457h0bll14